- Home
- / FluoroPharma Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
FluoroPharma Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$3.4 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 19, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|---|---|
| General and administrative expense | 2.1M | 1.5M | 3.0M | 3.4M | 2.5M | 1.7M |
| Operating expense total | 2.7M | 3.0M | 4.4M | 5.2M | 3.2M | 2.2M |
| EBIT | (3.4M) | (4.1M) | (4.4M) | (5.2M) | (3.2M) | (2.2M) |
| Interest income | 767.0 | 211.0 | 18.0 | |||
| Interest expense | 113.2K | 132.8K | 1.2M | 1.0M | 22.7K | 152.6K |
| Pre tax profit | (3.4M) | (4.0M) | (5.6M) | (4.1M) | (3.2M) | |
| Net Income | (3.4M) | (4.0M) | (5.6M) | (4.1M) | (3.2M) | (2.0M) |